Rothschild & Co Asset Management US’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-346,477
Closed -$36.2M 369
2017
Q4
$36.2M Sell
346,477
-129,771
-27% -$14.6M 0.38% 99
2017
Q3
$69.4M Sell
476,248
-23,803
-5% -$3.24M 0.76% 19
2017
Q2
$64.9M Sell
500,051
-10,075
-2% -$1.23M 0.73% 27
2017
Q1
$63.5M Buy
+510,126
New +$61M 0.73% 26
2014
Q2
Sell
-37,646
Closed -$2.63M 384
2014
Q1
$2.63M Sell
37,646
-232,464
-86% -$18.4M 0.06% 321
2013
Q4
$22.8M Sell
270,110
-2,966
-1% -$235K 0.51% 47
2013
Q3
$21M Sell
273,076
-98,124
-26% -$6.88M 0.46% 58
2013
Q2
$21.7M Buy
+371,200
New +$22.3M 0.51% 48

Other funds holding CELG

Rothschild & Co Asset Management US's CELG Position: Q1 2018 in Review

Rothschild & Co Asset Management US sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 346,477 shares — an estimated $36.2M sold.

Rothschild & Co Asset Management US first reported a position in CELG in Q2 2013 and held it in 8 quarters. The position peaked at $69.4M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Rothschild & Co Asset Management US reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 346,477 Celgene Corp shares in Q1 2018, an estimated $36.2M.
  • Rothschild & Co Asset Management US first reported a position in Celgene Corp in Q2 2013 and held it in 8 quarters.
  • Rothschild & Co Asset Management US's Celgene Corp position peaked at $69.4M in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Rothschild & Co Asset Management US's 13F filing for Q1 2018, filed 8 May 2018.